Corganics Signs Patient Access Partnership Agreement with OrthoLoneStar
DALLAS, March 8, 2023 /PRNewswire/ -- Corganics, healthcare professionals' most trusted and recommended clinical cannabinoid (CBD) company, today announced a patient access partnership with OrthoLoneStar, the largest independent orthopedic practice in Texas and one of the largest in the U.S. The partnership provides OrthoLoneStar patients access to Corganics' clinical CBD therapies throughout OrthoLoneStar's locations.
- DALLAS, March 8, 2023 /PRNewswire/ -- Corganics, healthcare professionals' most trusted and recommended clinical cannabinoid (CBD) company, today announced a patient access partnership with OrthoLoneStar , the largest independent orthopedic practice in Texas and one of the largest in the U.S.
- The partnership provides OrthoLoneStar patients access to Corganics' clinical CBD therapies throughout OrthoLoneStar's locations.
- "OrthoLoneStar cares deeply about the quality and safety of therapy options for our patients," said Anthony Brooks, CEO of OrthoLoneStar.
- "OrthoLoneStar has a reputation for excellence in delivering orthopedic care and we're honored to work with them on providing patient access to trusted CBD therapies," said Corganics Co-founder and CEO Chad Collins.